Vero Beach QB Champ Monds IV, a three-star prospect, is working with Rosenhaus Sports on Name, Image and Likeness deals.
Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) and monotherapy subgroup (8.2% vs 11.1%). Transition to NYHA class IV was ...